Ingenium Pharmaceuticals

Ingenium publishes biological characterization of first mouse model for kidney stones

The article describes a biologically well-characterized mouse model for cystinuria type I, a human disease caused by impaired renal function. The model closely mimics the human disease state and is expected to improve biomedical research in areas like disease analysis and drug testing.

SourceIngenium Pharmaceuticals·JournalHuman Molecular Genetics·DateSep 3, 2003

Ingenium publishes groundbreaking research on genetic basis for motor neuron degeneration

Researchers have discovered a genetic link between specific mutations in the Dnchc1 gene and selective death of motor neurons, causing diseases like ALS. The study provides new insight into the pathogenetic mechanism underlying MND.

SourceIngenium Pharmaceuticals·JournalScience·DateMay 1, 2003